|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
109.27(B) |
Last
Volume: |
4,233,984 |
Avg
Vol: |
8,368,014 |
52
Week Range: |
$48.64 - $77.71 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
304,513 |
421,705 |
996,293 |
2,118,674 |
Total Sell Value |
$22,679,618 |
$30,048,564 |
$60,765,476 |
$110,963,213 |
Total People Sold |
9 |
10 |
11 |
13 |
Total Sell Transactions |
14 |
25 |
43 |
79 |
End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Kucheman William |
SVP & Group President |
|
2007-07-01 |
4 |
D |
$15.48 |
$21,146 |
D/D |
(1,366) |
5,778 |
|
- |
|
Kucheman William |
SVP & Group President |
|
2007-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,300 |
7,144 |
|
- |
|
Best Lawrence C |
EVP |
|
2007-07-01 |
4 |
D |
$15.48 |
$64,629 |
D/D |
(4,175) |
238,014 |
|
- |
|
Best Lawrence C |
EVP |
|
2007-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
242,189 |
|
- |
|
Gilbert James |
EVP |
|
2007-07-01 |
4 |
D |
$15.48 |
$39,319 |
D/D |
(2,540) |
20,921 |
|
- |
|
Gilbert James |
EVP |
|
2007-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
23,461 |
|
- |
|
Nicholas Peter M |
Director |
|
2007-06-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
395,000 |
10,920,042 |
|
- |
|
Nicholas Peter M |
Director |
|
2007-06-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
209,461 |
11,315,042 |
|
- |
|
Leno Sam R |
CFO & EVP Finance & ISOfficer |
|
2007-06-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,500 |
|
- |
|
Quinn Lucia Luce |
Exec. Vice President-HR |
|
2007-05-31 |
4 |
D |
$15.67 |
$49,752 |
D/D |
(3,175) |
13,649 |
|
- |
|
Quinn Lucia Luce |
Exec. Vice President-HR |
|
2007-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
16,824 |
|
- |
|
Bartell Mark C |
SVP Global Sales/Mkt CRM |
|
2007-05-25 |
4 |
S |
$15.75 |
$13,044,911 |
D/D |
(828,250) |
1,812 |
|
- |
|
Bartell Mark C |
SVP Global Sales/Mkt CRM |
|
2007-05-25 |
4 |
OE |
$13.23 |
$11,544,801 |
D/D |
828,250 |
830,062 |
|
- |
|
Promerica Lp |
10% Owner |
|
2007-05-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,082,833) |
70,635,185 |
|
- |
|
Nicholas Peter M |
Director |
|
2007-05-21 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,564,142) |
70,635,185 |
|
- |
|
Nicholas Peter M |
Director |
|
2007-05-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
275,000 |
90,148,317 |
|
- |
|
Abele John E |
Director |
|
2007-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
7,238 |
54,305,520 |
|
- |
|
Reinhardt Uwe E |
Director |
|
2007-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
7,238 |
35,020 |
|
- |
|
Nicholas Peter M |
Director |
|
2007-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
7,238 |
90,423,317 |
|
- |
|
Fleishman Joel Lawrence |
Director |
|
2007-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
7,238 |
116,587 |
|
- |
|
Nicholas Peter M |
Director |
|
2007-05-07 |
4 |
S |
$16.54 |
$237,768 |
D/D |
(14,300) |
90,416,079 |
|
- |
|
Abele John E |
Director |
|
2007-05-07 |
4 |
S |
$16.46 |
$33,176 |
D/D |
(2,000) |
54,298,282 |
|
- |
|
Nicholas Peter M |
Director |
|
2007-05-04 |
4 |
S |
$16.15 |
$5,675,616 |
D/D |
(350,754) |
90,430,379 |
|
- |
|
Abele John E |
Director |
|
2007-05-04 |
4 |
S |
$16.13 |
$1,394,188 |
D/D |
(85,854) |
54,365,428 |
|
- |
|
Abele John E |
Director |
|
2007-05-04 |
4 |
OE |
$12.41 |
$2,246,210 |
D/D |
181,000 |
54,451,282 |
|
- |
|
1825 Records found
|
|
Page 68 of 73 |
|
|